Your mouth's health significantly impacts your entire body, new research reveals. Poor oral hygiene is linked to serious ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF). This is the first new therapy in more than 10 years to be approved for ...

Jascayd is the first new IPF therapy approved in over 10 years, addressing a rare and serious disease with limited treatments. FDA approval was based on Phase III trials showing reduced FVC decline ...

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...

This summer I wrote an article about my experience with a postsurgical pulmonary embolism, hoping that sharing my story would help others take their own medical warning signs seriously. Hundreds of ...

Pulmonary sarcoidosis is a condition that causes tiny groups of immune cells to clump in your lungs. These groups of cells form swollen, inflamed lumps called granulomas. Granulomas can make it hard ...

On May 9, in conjunction with passage of the New York State budget, Gov. Kathy Hochul signed into law an omnibus bill addressing matters related to state's Mental Hygiene Law (MHL). Of the various ...

Patients may be at an increased risk of pulmonary complications (PPCs) following mandibular facture surgery if they have certain predisposing factors, according to a study recently published in BMC ...

A subsegmental pulmonary embolism is a blood clot located on a distal, or distant and less central, branch of the pulmonary arteries. Treatment can depend on symptoms and risk factors. A subsegmental ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...